ATN-161

· Attenuon

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATN-161, covering 2007-12-06 to 2012-05-02. Get the full timeline:

Most recent: Clinical Trial Update: ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma [Phase 1, Phase 2]